| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Total Solutions or Total Disaster |
|
Main Subject - Total Solutions or Total Disaster
Business relationships need to provide you with the business you need. Whether you use an According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product alliance, a leads group or a Power Team, you need to make sure that you are dealing with ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in someone that is reliable, honest, and ethical. There have been many horror stories with r lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. elationships that have gone sour because one person did not live up to their side of the here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe argain. I worked with a person a few years back that wanted to develop a publishing house d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro . He had the money and I had the expertise. This was great, but I was blind as to the pit ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc alls. The first thing we did was form a fifty-fifty partnership. He decided that I could easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi be President of the company and he would take up the vice-presidents position. It worked nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ell for a few months until he decided that he did not like the way I was managing the bus and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ iness. Since we were fifty-fifty partners, we were at a stalemate. I could no longer do w ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi at I thought was best for the company and he could veto everything we tried to do.
< ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a r>
As a result, the company failed and we were both out of pocket. If we were experience dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod d in this type of scenario, it would have been better to appoint a CEO or President and l cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin t them have more than fifty percent so they could effectively lead. The moral standards o tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen f both parties were excellent but we were not able to work together which resulted in a d t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel saster both financially and personally. Even though I do not believe in burning bridges, ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust if we ever meet again, it would be extremely awkward.
Sometimes even the great y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products st of intentions do not bring the business. Business relationships need to be taken care . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de of and even pampered at times. If there is a sense that the relationship is not working, elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ou will need to avoid any disaster by letting the other person off the hook and moving on tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Gondola Shelving Demystified - Part 1 - The Layout The Office of the Future with Ergonomics in Mind - Part 2 5 Ways To Increase Security Levels
|